MiR-150 blocks MLL-AF9-associated leukemia through oncogene repression

Molecular Cancer Research

Volumn 11, Issue 8, 2013, Pages 912-922

  Bousquet, Marina ^a,g   Zhuang, Guoqing ^d   Meng, Cong ^d   Ying, Wei ^f   Cheruku, Patali S ^e   Shie, Andrew T ^a,b   Wang, Stephanie ^a,b   Ge, Guangtao ^c   Wong, Piu ^a   Wang, Gang ^d   Safe, Stephen ^d   Zhou, Beiyan ^d  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c LeapFrogRx Inc   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e Environmental Science and Technology Center   (United States)

^f TEXAS A AND M UNIVERSITY   (United States)

^g CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CBL PROTEIN; EARLY GROWTH RESPONSE FACTOR 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MALATE DEHYDROGENASE; MICRORNA; MICRORNA150; MIXED LINEAGE LEUKEMIA AF9 PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN MYB; SHORT HAIRPIN RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; HEMATOPOIESIS; IN VITRO STUDY; LEUKEMIA; LEUKEMIA CELL; MOUSE; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; STEM CELL;

ANIMALS; APOPTOSIS; CELL CYCLE; EARLY GROWTH RESPONSE PROTEIN 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; LEUKEMIA; MICE; MICE, INBRED C57BL; MICRORNAS; ONCOGENE PROTEINS, FUSION; ONCOGENES; PROTO-ONCOGENE PROTEINS C-CBL; PROTO-ONCOGENE PROTEINS C-MYB; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84882736736     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-13-0002-T     Document Type: Article

References (49)

1. Liedtke M, Cleary ML. Therapeutic targeting of MLL. Blood 2009; 113:6061-8.
2. Liu H, Cheng EH, Hsieh JJ.MLLfusions: pathways to leukemia. Cancer Biol Ther 2009;8:1204-11.
3. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007;7: 823-33.
4. So CW, Karsunky H, Passegue E, Cozzio A, Weissman IL, Cleary ML. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell 2003; 3:161-71.
5. Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. Similar MLL-Associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003;17: 3029-35.
6. Hess JL, Bittner CB, Zeisig DT, Bach C, Fuchs U, Borkhardt A, et al. Cmyb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood 2006;108:297-304.
7. Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, et al. An integrated approach to dissecting oncogene addiction implicates a myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev 2011;25:1628-40.
8. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
9. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303:83-6.
10. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010;10:111-22.
11. Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008;8:120-30.
12. Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008;15:352-8.
13. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. Mir-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A 2007; 104:7080-5.
14. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, et al. Mir-150 controls B cell differentiation by targeting the transcription factor c-myb. Cell 2007;131:146-59.
15. Hussein K, Theophile K, Busche G, Schlegelberger B, Gohring G, Kreipe H, et al. Significant inverse correlation of microRNA-150/myb and microRNA-222/p27 in myelodysplastic syndrome. Leuk Res 2010;34:328-34.
16. Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, Lo WL, et al. C-myb is an evolutionary conserved mir-150 target and mir-150/c-myb interaction is important for embryonic development. Mol Biol Evol 2008;25: 2189-98.
17. Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 2008;3:e2141.
18. Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, et al. Characterization of B-And T-lineage acute lymphoblastic leukemia by integrated analysis of microRNA and mrna expression profiles. Genes Chromosomes Cancer 2009;48:1069-82.
19. Liu H, Takeda S, Cheng EH, Hsieh JJ. Biphasic MLL takes helm at cell cycle control: implications in human mixed lineage leukemia. Cell Cycle 2008;7:428-35.
20. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8.
21. Schotte D, Chau JC, Sylvester G, Liu G, Chen C, van der Velden VH, et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 2009; 23:313-22.
22. Somervaille TC, Cleary ML. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006;10:257-68.
23. Bousquet M, Harris MH, Zhou B, Lodish HF. MicroRNA mir-125b causes leukemia. Proc Natl Acad Sci U S A 2010;107:21558-63.
24. Wong P, Iwasaki M, Somervaille TC, So CW, Cleary ML. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev 2007;21:2762-74.
25. Wong P, Iwasaki M, Somervaille TC, Ficara F, Carico C, Arnold C, et al. The mir-17-92 microRNApolycistron regulatesMLLleukemia stem cell potential by modulating p21 expression. Cancer Res 2010;70: 3833-42.
26. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are micro-RNA targets. Cell 2005;120:15-20.
27. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37: 495-500.
28. Baer MR, Augustinos P, Kinniburgh AJ. Defective c-myc and c-myb rna turnover in acute myeloid leukemia cells. Blood 1992;79:1319-26.
29. Bradley EW, Ruan MM, Oursler MJ. Novel pro-survival functions of the kruppel-like transcription factor egr2 in promotion of macrophage colony-stimulating factor-mediated osteoclast survival downstream of the mek/erk pathway. J Biol Chem 2008;283:8055-64.
30. Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S, et al. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood 2009;114:1859-63.
31. Pelicci PG, Lanfrancone L, Brathwaite MD, Wolman SR, Dalla-Favera R. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 1984;224:1117-21.
32. Rathinam C, Thien CB, Flavell RA, Langdon WY. Myeloid leukemia development in c-CBL ring finger mutant mice is dependent on FLT3 signaling. Cancer Cell 2010;18:341-52.
33. Yasar D, Karadogan I, Alanoglu G, Akkaya B, Luleci G, Salim O, et al. Array comparative genomic hybridization analysis of adult acute leukemia patients. Cancer Genet Cytogenet 2010;197:122-9.
34. KrivtsovAV, Feng Z, Armstrong SA. Transformation fromcommitted progenitor to leukemia stem cells. Ann N Y Acad Sci 2009;1176: 144-9.
35. Somervaille TC, Matheny CJ, Spencer GJ, Iwasaki M, Rinn JL, Witten DM, et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009;4:129-40.
36. Armstrong SA. MLL-AF9 transforms committed progenitors to leukemia stem cells by activation of a stem cell program (expt 2). GEO; 2005.
37. Broske AM, Vockentanz L, Kharazi S, Huska MR, Mancini E, Scheller M, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet 2009;41:1207-15.
38. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353: 1793-801.
39. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 2008;105:3945-50.
40. Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD, et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.Blood 2009;113:3754-64.
41. Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, et al. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 2009;114:3872-9.
42. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-61.
43. Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A 2008;105:15535-40.
44. Navarro A, Bea S, Fernandez V, Prieto M, Salaverria I, Jares P, et al. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in mantle cell lymphomas. Cancer Res 2009;69:7071-8.
45. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, et al. Modulation of microRNA expression in human T-cell development: targeting of notch3 by mir-150. Blood 2011;117:7053-62.
46. Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, et al. MicroRNAmediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008;14:843-53.
47. Jiang X, Huang H, Li Z, Li Y, Wang X, Gurbuxani S, et al. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLLassociated leukemia. Cancer Cell 2012;22:524-35.
48. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004;5:396-400.
49. Jin S, Zhao H, Yi Y, Nakata Y, Kalota A, Gewirtz AM. C-myb binds MLL through menin in human leukemia cells and is an important driver of MLL-Associated leukemogenesis. J Clin Invest 2010;120: 593-606.